Bamco Inc Axonics, Inc. Transaction History

Bamco Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $63 Million - $77.1 Million	-1,111,398 Reduced 61.81%	686,565 $47.4 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $87,303 - $112,710	-1,768 Reduced 0.1%	1,797,963 $112 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $126,464 - $162,526	-2,600 Reduced 0.14%	1,799,731 $101 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.41 Million - $1.77 Million	29,317 Added 1.65%	1,802,331 $91 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $4.18 Million - $5.37 Million	-70,100 Reduced 3.8%	1,773,014 $111 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $6.05 Million - $9.87 Million	153,200 Added 9.07%	1,843,114 $104 Million
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $726,145 - $1.07 Million	-14,520 Reduced 0.85%	1,689,914 $94.6 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $3.93 Million - $5.23 Million	66,452 Added 4.06%	1,704,434 $111 Million
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $6.78 Million - $8.83 Million	132,000 Added 8.77%	1,637,982 $104 Million
Q1 2021 May 19, 2021	BUY	$49.14 - $59.89 $11.1 Million - $13.5 Million	225,000 Added 17.56%	1,505,982 $90.2 Million
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $2.11 Million - $2.58 Million	50,000 Added 4.06%	1,280,982 $63.9 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $22.3 Million - $38.8 Million	974,982 Added 380.85%	1,230,982 $43.2 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $4.21 Million - $9.66 Million	256,000 New	256,000 $6.51 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.